Avenzo Therapeutics, Inc. filed a Form D with the Securities and Exchange Commission on 2025-09-05.
Avenzo Therapeutics, Inc. filed a Form D notice of an exempt securities offering with the SEC on September 5, 2025. The filing reports $47.23M sold. Its industry group is Biotechnology. It names Athena Countouriotis (Executive Officer, Director), Brian Sun (Executive Officer), Mohammad Hirmand (Executive Officer) (SEC Form D, September 5, 2025).
Is this your company?
Sell to companies like Avenzo Therapeutics, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2025-09-05 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Avenzo Therapeutics, Inc.
Free to see. No signup.
More on the people and the money behind Avenzo Therapeutics, Inc., from the filings we hold.
Biotechnology raises by companies based in California, filed in September 2025, largest first.
Get an email when Avenzo Therapeutics, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Avenzo Therapeutics, Inc. raises, hires or launches. No email unless you switch it on.
Watch Avenzo Therapeutics, Inc. →Get the full cited report on Avenzo Therapeutics, Inc.
What the filing shows about Avenzo Therapeutics, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Avenzo Therapeutics, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Avenzo Therapeutics, Inc.'s address as 12707 High Bluff Drive, Suite 200, San Diego, CA 92130.
Saved here on this device in the meantime, so nothing is lost either way.
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Order the Full Report on Avenzo Therapeutics, Inc. See pricing
Avenzo Therapeutics, Inc. is a registered filer with the SEC (CIK 1947742) and has filed since 2024-03-26. 3 filings are on record, the latest on 2025-09-05.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Avenzo Therapeutics, Inc.'s Form D of 2025-09-05 names Athena Countouriotis, Brian Sun, Mohammad Hirmand and 8 more as its officers, directors or promoters.
Its new offerings report $47.23M sold across 1 offering, as its own filings state.
A hollow marker is an amendment (Form D/A); a solid one is an original Form D. The larger marker is the filing this page is about.
Trailing twelve months. 766 filings in Biotechnology, totalled by week.
Athena Countouriotis is named as Executive Officer and Director on the Form D that Avenzo Therapeutics, Inc. filed with the SEC on 5 September 2025, one of 11 people that filing names.
Brian Sun is named as Executive Officer on the Form D that Avenzo Therapeutics, Inc. filed with the SEC on 5 September 2025, one of 11 people that filing names.
Mohammad Hirmand is named as Executive Officer on the Form D that Avenzo Therapeutics, Inc. filed with the SEC on 5 September 2025, one of 11 people that filing names.
Simeon George is named as Director on the Form D that Avenzo Therapeutics, Inc. filed with the SEC on 5 September 2025, one of 11 people that filing names.
Carl Gordon is named as Director on the Form D that Avenzo Therapeutics, Inc. filed with the SEC on 5 September 2025, one of 11 people that filing names.
Jakob Dupont, M.D., M.A. is named as Director on the Form D that Avenzo Therapeutics, Inc. filed with the SEC on 5 September 2025, one of 11 people that filing names.
Paolo Tombesi is named as Executive Officer on the Form D that Avenzo Therapeutics, Inc. filed with the SEC on 5 September 2025, one of 11 people that filing names.
Scott Lipman is named as Executive Officer on the Form D that Avenzo Therapeutics, Inc. filed with the SEC on 5 September 2025, one of 11 people that filing names.
Judith Li is named as Director on the Form D that Avenzo Therapeutics, Inc. filed with the SEC on 5 September 2025, one of 11 people that filing names.
Garry Nicholson is named as Director on the Form D that Avenzo Therapeutics, Inc. filed with the SEC on 5 September 2025, one of 11 people that filing names.
Patrick Machado is named as Director on the Form D that Avenzo Therapeutics, Inc. filed with the SEC on 5 September 2025, one of 11 people that filing names.
11 people named on the filing — 5 holding an executive role and 6 as directors only.
Named as of the 2025-09-05 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about Avenzo Therapeutics, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Avenzo Therapeutics, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Avenzo Therapeutics, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Avenzo Therapeutics, Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind Avenzo Therapeutics, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for Avenzo Therapeutics, Inc.. With no account yet, you sign up free and land on the result.
On these lists: Biotech raises in San Diego
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/avenzo-therapeutics-inc-form-d-25000001